Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/307% below fair value
$69.49−1.47 (-2.07%)
Close on Nov 20, 2026Market cap $221.24MP/E 21.2Yield –
Utah Medical Products gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Utah Medical Products's gross profit for the twelve months ending Jun 30, 2026 was $20.91M. For fiscal 2025 it was $22.00M, down 8.9% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is $32.20M in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.00M | -8.9% |
| FY2024 | Dec 31, 2024 | $24.14M | -19.6% |
| FY2023 | Dec 31, 2023 | $30.04M | -6.7% |
| FY2022 | Dec 31, 2022 | $32.20M | +4.1% |
| FY2021 | Dec 31, 2021 | $30.92M | +21.0% |
| FY2020 | Dec 31, 2020 | $25.55M | -13.3% |
| FY2019 | Dec 31, 2019 | $29.47M | +12.0% |
| FY2018 | Dec 31, 2018 | $26.31M | -0.3% |
| FY2017 | Dec 31, 2017 | $26.40M | +11.4% |
| FY2016 | Dec 31, 2016 | $23.69M | -2.0% |
| FY2015 | Dec 31, 2015 | $24.19M | -3.2% |
| FY2014 | Dec 31, 2014 | $24.98M | +2.9% |
| FY2013 | Dec 31, 2013 | $24.27M | -4.1% |
| FY2012 | Dec 31, 2012 | $25.31M | +13.0% |
| FY2011 | Dec 31, 2011 | $22.40M | +69.6% |
| FY2010 | Dec 31, 2010 | $13.21M | -4.2% |
| FY2009 | Dec 31, 2009 | $13.79M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.76M | -15.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.28M | -4.6% |
| Q4 FY2025 | Dec 31, 2025 | $5.26M | -25.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.60M | -23.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.60M | -27.7% |
| Q1 FY2025 | Mar 31, 2025 | $5.54M | -29.4% |
| Q4 FY2023 | Dec 31, 2023 | $7.10M | -14.8% |
| Q3 FY2023 | Sep 30, 2023 | $7.36M | -10.1% |
| Q2 FY2023 | Jun 30, 2023 | $7.74M | -5.1% |
| Q1 FY2023 | Mar 31, 2023 | $7.84M | +4.1% |
| Q4 FY2022 | Dec 31, 2022 | $8.33M | +2.7% |
| Q3 FY2022 | Sep 30, 2022 | $8.19M | +1.4% |
| Q2 FY2022 | Jun 30, 2022 | $8.15M | +4.7% |
| Q1 FY2022 | Mar 31, 2022 | $7.53M | +8.4% |
| Q4 FY2021 | Dec 31, 2021 | $8.11M | +11.7% |
| Q3 FY2021 | Sep 30, 2021 | $8.07M | +24.3% |
| Q2 FY2021 | Jun 30, 2021 | $7.79M | +57.3% |
| Q1 FY2021 | Mar 31, 2021 | $6.95M | +1.6% |
| Q4 FY2020 | Dec 31, 2020 | $7.27M | -7.0% |
| Q3 FY2020 | Sep 30, 2020 | $6.50M | -12.0% |
| Q2 FY2020 | Jun 30, 2020 | $4.95M | -34.0% |
| Q1 FY2020 | Mar 31, 2020 | $6.84M | +0.9% |
| Q4 FY2019 | Dec 31, 2019 | $7.81M | +28.0% |
| Q3 FY2019 | Sep 30, 2019 | $7.38M | +17.2% |
| Q2 FY2019 | Jun 30, 2019 | $7.50M | +7.4% |
| Q1 FY2019 | Mar 31, 2019 | $6.77M | -2.2% |
| Q4 FY2018 | Dec 31, 2018 | $6.11M | -5.6% |
| Q3 FY2018 | Sep 30, 2018 | $6.29M | -3.1% |
| Q2 FY2018 | Jun 30, 2018 | $6.98M | +1.3% |
| Q1 FY2018 | Mar 31, 2018 | $6.92M | +5.9% |
| Q4 FY2017 | Dec 31, 2017 | $6.47M | +18.9% |
| Q3 FY2017 | Sep 30, 2017 | $6.50M | +12.5% |
| Q2 FY2017 | Jun 30, 2017 | $6.89M | +10.3% |
| Q1 FY2017 | Mar 31, 2017 | $6.54M | +5.0% |
| Q4 FY2016 | Dec 31, 2016 | $5.44M | -7.7% |
| Q3 FY2016 | Sep 30, 2016 | $5.78M | – |
| Q2 FY2016 | Jun 30, 2016 | $6.25M | – |
| Q1 FY2016 | Mar 31, 2016 | $6.22M | – |
| Q4 FY2015 | Dec 31, 2015 | $5.90M | – |
See a number that looks wrong?